Latest News about BSX
Recent news which mentions BSX
Why Is Boston Scientific Stock Trading Lower Premarket Today?
February 02, 2022
Tickers
BSX
From Benzinga
A few more stock pullbacks, and then a big one, are coming, warns this manager. Here’s how investors should prepare.
February 02, 2022
From MarketWatch
Earnings Scheduled For February 2, 2022
February 02, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
From Benzinga
Here's Why Medtronic Stock Dipped 11% in November
December 08, 2021
From Motley Fool
These are Wall Street’s 20 favorite stocks as the Fed’s Powell jolts the market with taper talk
November 30, 2021
From MarketWatch
Nevro to pay Boston Scientific $20 million in patent infringement case
November 01, 2021
From MarketWatch
Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript
October 27, 2021
Tickers
BSX
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
From Benzinga
Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal
October 06, 2021
Tickers
BSX
From Benzinga
FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants
September 29, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads
September 20, 2021
Tickers
BSX
From Benzinga
'Fast Money Halftime Report' Picks For September 15
September 15, 2021
From Benzinga
TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today
September 10, 2021
From InvestorPlace
From Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
From MarketWatch
Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh
August 17, 2021
Tickers
BSX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.